Accelerating Innovation at Leica Biosystems
DANAHER CORPORATION
Reconciliation of GAAP to Adjusted P&L Metrics
the VWAP per share of the Company's common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day
immediately before April 15, 2022 and April 15, 2023 for the MCPS Series A and Series B, respectively. For the calculation of net earnings per common share
from continuing operations, the impact of the dilutive MCPS are calculated under the if-converted method and the related MCPS dividends are excluded. For the
purposes of calculating adjusted earnings per common share from continuing operations, the Company has excluded the paid and anticipated MCPS cash
dividends and assumed the "if-converted" method of share dilution (the incremental shares of common stock deemed outstanding applying the "if-converted"
method of calculating share dilution only with respect to any MCPS the conversion of which would be dilutive in the particular period are referred to as the
"Converted Shares") for any MCPS that were anti-dilutive for the given period. For additional information about the impact of the MCPS on the calculation of
diluted EPS, see note 3 in the Adjusted Average Common Stock and Common Equivalent Diluted Shares Outstanding table below.
15View entire presentation